Despite currency and tariff challenges, Getinge AB (GNGBY) reports solid cash flow and strategic product launches to bolster future growth.

April 21 (Reuters) - Swedish medical equipment maker Getinge reported a bigger than expected drop in first-quarter core earnings on Tuesday, citing a decline in ventilator sales and lower investments ...

"We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos, President & CEO at Getinge. The medtech company's ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

In its second acquisition of 2023—and its largest in several years—Swedish devicemaker Getinge has set its sights on High Purity New England, which churns out a range of products used throughout the ...

GETINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Getinge Group (STO:GETIB) has recently performed a strategic review to clarify its long-term strategy for ensuring sustainable and profitable growth.

Swedish medical equipment maker Getinge reported an 18% decline in first-quarter adjusted EBITA on Tuesday, missing analyst ...

GÖTEBORG, Sweden, July 24, 2020 /PRNewswire/ -- Today Getinge announces its intention to become a CO₂neutral company by 2025. The target will be reached by a stepwise approach in several areas and ...

GOTHENBURG, Sweden, Dec. 23, 2021 /PRNewswire/ -- Getinge announces the acquisition of 100% of the equity interest in Talis Clinical LLC, a US-based leading innovator of High Acuity cloud-based ...

GOTHENBURG, Sweden, March 26, 2026 /PRNewswire/ -- Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and ...

Several years into the process of rectifying potential breaches in the sterile packaging of its life support systems—a process that has been littered with field correction notices and FDA-rated ...